By Izzy Wood (Drug Target Review)2023-02-20T11:57:45
To help people with opioid addiction, US researchers are turning to AI to create and optimise potential new drugs.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-09-27T13:56:39
Sponsored by Euretos
2023-03-30T09:15:30
Sponsored by Halo Labs
2023-03-28T11:38:32
Sponsored by Bio-Techne
2025-09-18T12:00:00
Sponsored by Benchling
2024-01-19T07:40:55
Sponsored by Euretos
Site powered by Webvision Cloud